Key Developments: McKesson Corp (MCK)

MCK on New York Consolidated

194.31USD
22 Sep 2014
Price Change (% chg)

$-1.48 (-0.76%)
Prev Close
$195.79
Open
$194.84
Day's High
$195.30
Day's Low
$193.25
Volume
631,881
Avg. Vol
940,105
52-wk High
$200.00
52-wk Low
$127.45

Search Stocks

Latest Key Developments (Source: Significant Developments)

McKesson Corp raises FY 2015 EPS outlook
Thursday, 31 Jul 2014 07:30am EDT 

McKesson Corp:Now expects FY 2015 adjusted earnings per diluted share from continuing operations between $10.50 and $10.90.FY 2015 EPS of $10.66 - Thomson Reuters I/B/E/S.  Full Article

McKesson Corp declares regular dividend
Wednesday, 30 Jul 2014 04:10pm EDT 

McKesson Corp:Declares regular dividend of 24 cents per share on Common Stock.Dividend will be payable on Oct. 1, to stockholders of record on Sept. 2.  Full Article

McKesson extends pharmaceutical distribution agreement with CVS Caremark
Wednesday, 30 Jul 2014 09:00am EDT 

McKesson Corp:Announces a three-year extension of its existing distribution agreement with CVS Caremark through June, 2019.  Full Article

McKesson Corp reaffirms FY 2015 EPS outlook
Wednesday, 25 Jun 2014 08:00am EDT 

McKesson Corp:Reaffirmed its earnings guidance for FY 2015 and the underlying key assumptions provided in its press release of May 12.FY 2015 EPS of $10.66 - Thomson Reuters I/B/E/S.  Full Article

Symphony Technology Group to acquire European Healthcare Software Businesses from McKesson Corp
Monday, 2 Jun 2014 06:00am EDT 

McKesson Corp:Symphony Technology Group announces that it has agreed to acquire several of the European healthcare technology operations of McKesson Corporation (McKesson).These operations include the UK Health and Social Care business, including System C and Liquidlogic, as well as McKesson's software operations in France and the Netherlands.  Full Article

McKesson declares quarterly dividend
Wednesday, 28 May 2014 04:10pm EDT 

McKesson Corp:Declares a regular dividend of twenty-four cents per share on Common Stock.Payable on July 1, to stockholders of record on June 9.  Full Article

McKesson Corp gives FY 2015 EPS guidance in line with analysts' estimates
Monday, 12 May 2014 04:10pm EDT 

McKesson Corp:Expects adjusted earnings per diluted share between $10.40 and $10.80 for FY 2015.FY 2015 EPS of $10.58 - Thomson Reuters I/B/E/S.  Full Article

McKesson Corp launches takeover offer for remaining Celesio shares
Friday, 28 Feb 2014 09:05am EST 

McKesson Corp:Launched voluntary public takeover offer for remaining outstanding shares of Celesio AG through its indirect wholly-owned subsidiary Dragonfly GmbH & Co. KGaA.There are no closing conditions in relation to the Takeover Offer.McKesson exceeds 75 pct ownership of Celesio shares on fully diluted basis.  Full Article

McKesson Corp and Rite Aid expand distribution agreement
Tuesday, 18 Feb 2014 08:45am EST 

McKesson Corp and Rite Aid Corp:Signs of an expanded distribution agreement to include both brand and generic pharmaceuticals.Says new five-year agreement, which extends through March 2019, creates efficiencies for both companies by leveraging the strength.Says agreement leverages the strength of Rite Aid national drugstore chains in the United States and McKesson as a leader in pharmaceutical sourcing and supply chain management.  Full Article

McKesson Corp completes previously announced agreements, secures Celesio Acquisition
Thursday, 6 Feb 2014 09:00am EST 

McKesson Corp:Says it has completed the previously announced agreement with Franz Haniel & Cie. GmbH to acquire their entire holding of Celesio AG shares.Says it has also confirmed it has completed the previously announced agreement with an affiliate of Elliott Management to acquire Celesio convertible bonds.Says it now exceeds 75 pct ownership of Celesio shares on a fully diluted basis.  Full Article

UPDATE 1-McKesson pays $18 mln in temperature monitor false claims case

Aug 8 - McKesson Corp agreed to pay $18 million to settle U.S. charges that it violated its contract with the U.S. Centers for Disease Control and Prevention by falsely assuring that it had been shipping vaccines at the correct temperature.

Search Stocks